1. What is KL-6? KL-6 is recognized as a valid indicator of lung injury and pulmonary fibrosis, and is expressed on the surface of type II alveolar epithelial cells, in normal lung tissue and terminal bronchiolar epithelial cells. It is expressed in very small amounts, and is enhanced in degenerative (proliferating, regenerating, or damaged) type II alveolar epithelial cells, which is directly rel...
The most common respiratory symptoms of COVID 19 patients include dry cough, dyspnea, pneumonia, etc., and in severe cases, white lung can appear, and respiratory failure is life-threatening. Even after rehabilitation, many people still coughed, and many people panicked, and took the initiative to go to the hospital to ask for a film to see the condition of their lungs. COVID 19 infection c...
Interstitial lung diseases (ILDs) represent a diverse group of disorders characterized by inflammation and scarring of lung tissue. These conditions can lead to significant respiratory impairment and pose challenges for diagnosis and treatment. Understanding the underlying mechanisms and identifying reliable biomarkers are crucial for the effective management of ILDs. One of the critical biomarker...